[1] |
JING Tianshu, LU Guotao, WANG Shengfeng.
Risks of Pancreatic Adverse Events Associated with Tirzepatide: a Disproportionality Analysis Using Spontaneous Adverse Event Reporting System Data
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 669-673.
|
[2] |
YU Wenlu, ZHANG Hong.
Research Progress in Applications of Strychnine Semen in Orthopedics and Traumatology
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 116-120.
|
[3] |
JIANG Hailun, ZHOU Xinbo, XIAO Dian, ZHONG Wu, LI Song.
Proteolysis targeting chimeric drugs and their potential risks
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(7): 730-734.
|
[4] |
GAO Haiyun, CHEN Yuxin, LI Yao, LI Hui, LIU Tianrui, YUAN Yuan.
Herbal textual research and adverse reaction study of Coprinus comatus
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 502-506.
|
[5] |
DILHUMAR Dilmurat, SHI Wei, WANG Jiabo, GAO Yuan.
Research progress in safe use of Psoralea corylifolia based on evolution of toxicity/efficacy
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 939-945.
|
[6] |
WANG Shan, HUANG Jukai, WU Honghui, WEN Yalu, ZHANG Li, WANG Jianhua, YANG Xiaohui.
Evaluation of a KKAy animal model of type 2 diabetes mellitus combined with nonalcoholic fatty liver disease
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 273-276.
|
[7] |
YANG Liu, SHI Fenghua, MA Lijuian.
Logistic regression analysis of influencing factors of adverse drug reaction of glimepiride and their effect on treatment of T2DM
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 1030-1034.
|
[8] |
MU Sicong, WANG Zhuo, LU Junyang, JI Liwei, LIU Xin.
Effects of pioglitazone on plasma adiponectin in patients with type 2 diabetes mellitus: a Meta-analysis
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 1015-1018.
|
[9] |
XIANG Yufang, SUN Hui, CHEN Yue, WANG Ningsheng, LUO Shishu, ZHANG Zhi, FENG Bianling.
Medication safety and combined medication in patients with type 2 diabetes mellitus
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(3): 313-316.
|
[10] |
CHEN Qiying, HUANG Dandan, CHEN Tianyu.
Safety of High-dose Canagliflozin for Type 2 Diabetes Mellitus: A Meta Analysis
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(2): 150-154.
|
[11] |
WU Fei, LI Min, FANG Yuting, CHEN Yongwu, SHEN Aizong.
Active Monitoring of Adverse Drug Reactions Caused by Lopinavir/ritonavir in Treating Coronavirus Disease 2019
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(2): 105-109.
|
[12] |
FENG Jing, ZHENG Hu-lin.
Clinical Efficacy of Thioctic Acid Injection in Diabetic Patients with Cerebral Infarction and Its Influence on Serum Inflammatory Cytokines Level
[J]. Chinese Journal of Pharmacovigilance, 2016, 13(6): 330-332.
|
[13] |
YU Chao, XU Yu-ming, XU Jin, WAN Kai-hua, YUAN Xing-dong, LI Sui, ZHOU Juan .
Progress of Clinical Application and Safety of Tetanus Antitoxin
[J]. Chinese Journal of Pharmacovigilance, 2016, 13(1): 36-41.
|
[14] |
JIN Xin-min .
Effects of Metformin on Ventricular Remodeling in Patients with Primary Hypertension and Type 2 Diabetes Mellitus
[J]. Chinese Journal of Pharmacovigilance, 2016, 13(1): 9-12.
|
[15] |
LI Guo-qiang, WANG Ya-ping, WANG Zhi-zhong, ZHAO Wen, WANG Jing.
Clinical Effects of Shenqi Jiangtang Granule Combined with Gliquidone on 170 Patients with Type 2 Diabetes Mellitus
[J]. Chinese Journal of Pharmacovigilance, 2011, 8(2): 68-70.
|